Research Frontiers Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | - |
| EPS actual | -$0.0200 |
| Revenue estimate | - |
| Revenue actual | 136.319K |
| Release date | Mar 05, 2026 |
| EPS estimate | - |
| EPS actual | -$0.0200 |
| Revenue estimate | - |
| Revenue actual | 72.123K |
| Release date | Nov 06, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0100 |
| Revenue estimate | - |
| Revenue actual | 359.444K |
| Release date | Aug 07, 2025 |
| EPS estimate | - |
| EPS actual | -$0.0200 |
| Revenue estimate | - |
| Revenue actual | 129.903K |
Last 4 Quarters for Research Frontiers
Below you can see how REFR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 07, 2025 |
| Price on release | $1.57 |
| EPS estimate | - |
| EPS actual | -$0.0200 |
| Date | Price |
|---|---|
| Aug 01, 2025 | $1.60 |
| Aug 04, 2025 | $1.58 |
| Aug 05, 2025 | $1.57 |
| Aug 06, 2025 | $1.53 |
| Aug 07, 2025 | $1.57 |
| Aug 08, 2025 | $1.53 |
| Aug 11, 2025 | $1.50 |
| Aug 12, 2025 | $1.50 |
| Aug 13, 2025 | $1.51 |
| 4 days before | -1.88% |
| 4 days after | -3.82% |
| On release day | -2.55% |
| Change in period | -5.63% |
| Release date | Nov 06, 2025 |
| Price on release | $1.60 |
| EPS estimate | - |
| EPS actual | -$0.0100 |
| Date | Price |
|---|---|
| Oct 31, 2025 | $1.94 |
| Nov 03, 2025 | $1.88 |
| Nov 04, 2025 | $1.75 |
| Nov 05, 2025 | $1.71 |
| Nov 06, 2025 | $1.60 |
| Nov 07, 2025 | $1.58 |
| Nov 10, 2025 | $1.57 |
| Nov 11, 2025 | $1.74 |
| Nov 12, 2025 | $1.83 |
| 4 days before | -17.53% |
| 4 days after | 14.38% |
| On release day | -1.25% |
| Change in period | -5.67% |
| Release date | Mar 05, 2026 |
| Price on release | $0.99 |
| EPS estimate | - |
| EPS actual | -$0.0200 |
| Date | Price |
|---|---|
| Feb 27, 2026 | $1.00 |
| Mar 02, 2026 | $1.03 |
| Mar 03, 2026 | $1.01 |
| Mar 04, 2026 | $1.01 |
| Mar 05, 2026 | $0.99 |
| Mar 06, 2026 | $0.98 |
| Mar 09, 2026 | $0.94 |
| Mar 10, 2026 | $0.93 |
| Mar 11, 2026 | $0.90 |
| 4 days before | -0.523% |
| 4 days after | -8.71% |
| On release day | -1.01% |
| Change in period | -9.18% |
| Release date | May 07, 2026 |
| Price on release | $0.83 |
| EPS estimate | - |
| EPS actual | -$0.0200 |
| Date | Price |
|---|---|
| May 01, 2026 | $0.88 |
| May 04, 2026 | $0.87 |
| May 05, 2026 | $0.87 |
| May 06, 2026 | $0.88 |
| May 07, 2026 | $0.83 |
| May 08, 2026 | $0.754 |
| May 11, 2026 | $0.760 |
| May 12, 2026 | $0.776 |
| May 13, 2026 | $0.790 |
| 4 days before | -5.10% |
| 4 days after | -5.17% |
| On release day | -9.48% |
| Change in period | -10.01% |
Research Frontiers Earnings Call Transcript Summary of Q1 2026
Research Frontiers' Q1 2026 results were affected by accounting timing (ASC 606) and the spread of minimum annual royalties, which made reported revenues look weaker than the underlying business activity. Sequentially, royalties from automotive and aircraft markets rose versus Q4 2025. The company's cash position was strengthened via a financing with accredited investors; cash was ~$1.28M at March 31, 2026 (up from ~$664k at year-end 2025) and the company remains debt-free. Operating and R&D expenses declined year-over-year. A primary near-term issue is the French rehabilitation proceedings affecting licensee Gauzy and its Vision Systems subsidiary, which temporarily slowed payments and some R&D work; however, payments have begun loosening and a May 12 court hearing could approve a continuation plan that management believes would leave Gauzy leaner, better capitalized and a stronger partner. Contingency plans are in place if the court outcome differs. Operational updates: SPD production, customer programs and development (including black SPD) continue across automotive, aerospace and architectural markets; black SPD progress could materially expand addressable markets by improving color/aesthetics. Management emphasized SPD’s unique commercial track record (serial production with multiple OEMs), continued interest from OEMs and ongoing retrofit and specialty transportation opportunities. The company did not hold live Q&A to avoid impacting ongoing legal proceedings but remains available to investors after the call.
Sign In
Buy REFR